imagine a treatment for tardive dyskinesia

Do you have

Unintentional, Uncontrollable Movements

in your face, hands, feet, or torso?

It could be tardive dyskinesia (TD).1

AUSTEDO® is a prescription medicine used to treat adults with tardive dyskinesia (TD).2

In clinical studies, people were able to continue taking mental health medications like antipsychotics or antidepressants while on AUSTEDO®.3

Now it's your move


See how austedo® may help

What is TD?

If you experience unintentional, uncontrollable movements it could be tardive dyskinesia. TD appears as mild to severe twitching, shaking or jerking in the hands, feet, face, or torso. Involuntary blinking, tongue movements, and other unintentional, uncontrollable movements can also be signs of TD.1,4,5

Silhouette of Person
Foot Silhouette

Ready to learn more?

The AUSTEDO® Patient Brochure provides important information about treatment with AUSTEDO®, while the Doctor Discussion Guide helps you work with your doctor to determine if AUSTEDO® is right for you.

get resources

Receive Updates

Sign up to have information about AUSTEDO® tablets and tardive dyskinesia emailed to you.

Teva is committed to helping you find affordable access to AUSTEDO®

So you can start and stay on treatment as prescribed by your doctor

AUSTEDO® Copay Program for Tardive Dyskinesia

*For eligible individuals with a valid AUSTEDO® prescription. Please note this offer is not available for patients eligible for Medicare, Medicaid or any other government payer coverage. Please review complete Terms and Conditions.

*For eligible individuals with a valid AUSTEDO® prescription.
Please note this offer is not available for patients eligible for Medicare, Medicaid or any
other government payer coverage. Please review complete Terms and Conditions.

You are about to leave this site

You are about to leave and enter a website operated by a third party. Teva is not responsible for and does not control the content contained on this third-party website linked to

Are you a healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

Approved Uses

AUSTEDO® is a prescription medicine that is used to treat:

  • the involuntary movements (chorea) of Huntington’s disease. AUSTEDO® does not cure the cause of the involuntary movements, and it does not treat other symptoms of Huntington’s disease, such as problems with thinking or emotions.
  • movements in the face, tongue, or other body parts that cannot be controlled (tardive dyskinesia).

It is not known if AUSTEDO® is safe and effective in children.

Important Safety Information

AUSTEDO® can cause serious side effects in people with Huntington’s disease, including: depression, suicidal thoughts, or suicidal actions. Do not start taking AUSTEDO® if you are depressed (have untreated depression or depression that is not well controlled by medicine) or have suicidal thoughts. Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts or feelings. This is especially important when AUSTEDO® is started and when the dose is changed. Call your healthcare provider right away if you become depressed, have unusual changes in mood or behavior, or have thoughts of suicide.

Do not take AUSTEDO® if you:

  • have Huntington’s disease and are depressed or have thoughts of suicide.
  • have liver problems.
  • are taking a monoamine oxidase inhibitor (MAOI) medicine. Do not take an MAOI within 14 days after you stop taking AUSTEDO®. Do not start AUSTEDO® if you stopped taking an MAOI in the last 14 days. Ask your healthcare provider or pharmacist if you are not sure.
  • are taking reserpine. Do not take medicines that contain reserpine (such as Serpalan® and Renese®-R) with AUSTEDO®. If your healthcare provider plans to switch you from taking reserpine to AUSTEDO®, you must wait at least 20 days after your last dose of reserpine before you start taking AUSTEDO®.
  • are taking tetrabenazine (Xenazine®). If your healthcare provider plans to switch you from tetrabenazine (Xenazine®) to AUSTEDO®, take your first dose of AUSTEDO® on the day after your last dose of tetrabenazine (Xenazine®).
  • are taking valbenazine (Ingrezza®).

Other possible serious side effects include:

  • Irregular heartbeat (QT prolongation). AUSTEDO® increases your chance of having certain changes in the electrical activity in your heart. These changes can lead to a dangerous abnormal heartbeat. Taking AUSTEDO® with certain medicines may increase this chance. If you are at risk of QT prolongation, your healthcare provider should check your heart before and after increasing your AUSTEDO® dose above 24 mg a day.
  • Neuroleptic Malignant Syndrome. Call your healthcare provider right away and go to the nearest emergency room if you develop these signs and symptoms that do not have another obvious cause: high fever, stiff muscles, problems thinking, very fast or uneven heartbeat, or increased sweating.
  • Restlessness. You may get a condition where you feel a strong urge to move. This is called akathisia.
  • Parkinsonism. Symptoms include: slight shaking, body stiffness, trouble moving, trouble keeping your balance, or falls.

Sleepiness (sedation) is a common side effect of AUSTEDO®. While taking AUSTEDO®, do not drive a car or operate dangerous machinery until you know how AUSTEDO® affects you. Drinking alcohol and taking other drugs that may also cause sleepiness while you are taking AUSTEDO® may increase any sleepiness caused by AUSTEDO®.

The most common side effects of AUSTEDO® in people with Huntington’s disease include sleepiness (sedation), diarrhea, tiredness, and dry mouth.

The most common side effects of AUSTEDO® in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia).

These are not all the possible side effects of AUSTEDO®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please read the accompanying Medication Guide.

References: 1. Warikoo N, Schwartz T, Citrome L. Tardive dyskinesia. In: Aguilar, M, ed. Antipsychotic Drugs: Classification, Pharmacology and Long-Term Health Effects. Hauppauge, NY: Nova Science Publishers, Inc. 2013:235-258. 2. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Teva Pharmaceuticals USA, Inc. 3. Data on file. Teva Neuroscience, Inc. 4. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov. 2013;3:1-11. 5. Sharing the impact of tardive dyskinesia. National Alliance on Mental Illness website. Accessed September 4, 2019.